GlassScriptPhysician profile
Katrice L Herndon Ogunleye
NPI 1407969827
$6,669.19
in general payments reported to CMS, 2019-2025
36 companies · $1,175 in 2025
The $1,175 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $712 · 2020: $241 · 2021: $1,067 · 2022: $694 · 2023: $1,547 · 2024: $1,234 · 2025: $1,175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,956.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,955.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,096.17 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Glaxosmithkline, LLC. | $848.50 | 2019-2025 | Arexvy, Trelegy Ellipta, Bexsero |
| Abbvie INC. | $657.25 | 2019-2024 | |
| Lilly USA, LLC | $415.55 | 2019-2025 | Mounjaro, Jardiance |
| Teva Pharmaceuticals USA, INC. | $358.10 | 2019-2025 | Austedo Xr |
| Abbott Laboratories | $334.63 | 2022-2023 | Freestyle Libre 2, Freestyle Libre 3 |
| Amgen INC. | $250.34 | 2019-2024 | Repatha |
| Aimmune Therapeutics, INC. | $207.19 | 2024-2025 | Zenpep |
| Boehringer Ingelheim Pharmaceuticals, INC. | $199.57 | 2019-2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $189.85 | 2021-2023 | |
| Novo Nordisk INC | $159.15 | 2021-2025 | Rybelsus, Ozempic |
| Exact Sciences Corporation | $158.00 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Boston Scientific Corporation | $153.02 | 2023-2024 | Watchman Access System, Wavewriter Alpha Prime 16 |
| Novartis Pharmaceuticals Corporation | $151.05 | 2019-2022 | |
| Alnylam Pharmaceuticals INC. | $139.71 | 2023 | Amvuttra |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $138.97 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $130.23 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $129.04 | 2021 | |
| Modernatx, INC. | $120.67 | 2023 | Moderna Covid-19 Vaccine |
| Sanofi-Aventis U.S. LLC | $117.59 | 2021-2022 | |
| Abiomed | $113.25 | 2025 | |
| Sanofi Pasteur INC. | $111.16 | 2023 | |
| Nestle Healthcare Nutrition INC. | $110.35 | 2020-2023 | |
| Dexcom, INC. | $103.55 | 2024-2025 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $74.77 | 2024-2025 | Veozah |
| Biohaven Pharmaceutical Holding Company LTD. | $36.47 | 2022 | |
| Corcept Therapeutics | $26.36 | 2025 | Korlym |
| Biogen, INC. | $20.63 | 2023 | Spinraza |
| Neurocrine Biosciences, INC. | $19.08 | 2024 | Ingrezza |
| Becton, Dickinson and Company | $15.59 | 2019 | |
| Intuitive Surgical, INC. | $14.77 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $14.42 | 2025 | Zoryve |
| Shield Therapeutics INC | $14.34 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $13.47 | 2025 | Caplyta |
| Vivaquant INC, Dba Rhythm Express | $13.40 | 2025 | Rhythm Express |
| Takeda Pharmaceuticals U.S.A., INC. | $13.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katrice Herndon Ogunleye listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.